| Financial Year |
March 31 2023 |
| Monetary Funds |
143,408,166.98 |
| Held-for-trading Financial Assets |
207,513,893.16 |
| Notes Receivable |
48,694,876.08 |
| Accounts Receivable |
98,778,648.57 |
| Advances to Suppliers |
19,306,395.72 |
| Other Receivables |
463,917.30 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
83,423,079.62 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
10,108,032.78 |
| Total Current Assets |
639,739,569.70 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
283,956,591.15 |
| Under-construction Projects |
157,958,503.62 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
53,339,630.41 |
| R&D expenses |
-- |
| Goodwill |
39,126,854.84 |
| Long-Term Deferred and Prepaid Expenses |
921,527.16 |
| Deferred Income Tax Assets |
10,923,870.18 |
| Other Non-Current Assets |
20,756,043.16 |
| Sub-Total of Non-Current Assets |
566,983,020.52 |
| Total Assets |
1,206,722,590.22 |
| Short-Term Loans |
40,009,763.91 |
| Trading Financial liabilities |
-- |
| Notes Payable |
137,480,764.80 |
| Accounts Payable |
75,059,587.90 |
| Accounts Received In Advance |
105,050.00 |
| Employee Compensation Payable |
7,244,472.29 |
| Taxes Payable |
1,823,313.61 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
6,943,402.11 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
33,862,287.44 |
| Sub-Total of Current Liabilities |
313,530,802.59 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
15,900,914.99 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
53,060,335.83 |
| Total Liabilities |
366,591,138.42 |
| Paid-In Capital(Or Share Stock) |
234,460,291.00 |
| Capital Surplus |
65,361,428.60 |
| Surplus Reserve |
73,444,882.92 |
| LESS:Treasury Stock |
5,244,848.10 |
| Undistributed Profits |
403,888,167.86 |
| Minority Stockholder's Interest |
67,729,903.77 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
772,401,548.03 |
| Owner's Equity（Stockholder's Equity） |
840,131,451.80 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,206,722,590.22 |
